Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_assertion type Assertion NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_head.
- NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_assertion wasGeneratedBy ECO_0000203 NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_provenance.
- NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_assertion wasDerivedFrom befree-2016 NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_provenance.
- NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_assertion SIO_000772 17717597 NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_provenance.
- NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_assertion evidence source_evidence_literature NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_provenance.
- NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_assertion description "[Furthermore, pharmacologic doses of FTY720 remarkably suppress in vivo p210/p190(BCR/ABL)-driven [including p210/p190(BCR/ABL)(T315I)] leukemogenesis without exerting any toxicity.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626491.RAf4KGuxC94FkbNYa97iTz3QfAmdbqzs7JIGZvfhEmp2U130_provenance.